Joshua Schiffman, CEO and Co-Founder of Peel Therapeutics, shared on LinkedIn:
“People never cease to amaze me.
I’m deeply grateful to Kate Peytavin, a gifted rising recording artist who is using her voice not only through music but also to help families affected by Li-Fraumeni Syndrome, an inherited cancer predisposition syndrome caused by a mutation in the TP53 gene.
Kate recently launched the Cornbread Foundation, inspired by her own family’s experience. The foundation will support our academic laboratory’s ongoing work to try to translate the remarkable cancer-fighting biology of elephant p53 into potential new treatments for patients.
Thank you, Kate, for turning your talent and personal experience into hope for so many others. I’m humbled and excited to see where your music and philanthropy will lead.
Learn more about Kate and the Cornbread Foundation.”
You can also read:
TP53 Gain-of-Function Mutations May Signal Early Osimertinib Resistance in EGFR-Mutant NSCLC
